FGFR2 and hepatocellular carcinoma: Finally, to elucidate the link between this intricate mechanism and TRPA1-FGFR2 interaction, we treated HCC-515 cells with SS media, exosomes, CM (DMA), and miR-142-3p inhibitor (Fig. 6k).